A

Altimmune

D
ALT
USD
-1.06
(-11.1403%)
Market Closed
187,701.00
حجم التداول
-1.25
الربح لكل سهم
-
العائد الربحي
-5.184049
P/E
600,904,890.71
حجم السوق
اليوم
-11.1403%
1 اسبوع
13.338%
1 شهر
31.493%
6 اشهر
8.259%
12 اشهر
253.027%
بداية السنة
-24.878%
كل الوقت
-99.028%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Altimmune

Sector:
Healthcare
Industry:
Biotechnology
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
هل تحتاج مساعدة او لديك استفسار؟